Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma

Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma.

Leukemia·2018

Drug response prediction in high-risk multiple myeloma.

Gene·2017

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.

Nature communications·2017

Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma.

Leukemia·2017

Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker.

Blood cancer journal·2017

Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma.

Leukemia·2016

INSR Armoring Protects CAR-NK and CAR-T Cells Against Tumor Stroma-Induced CAR Shedding by Maintaining Cholesterol Homeostasis.

Cancer research·2026

Sodium-Glucose Cotransporter SGLT2 Supports Metabolic Fitness and Ferroptosis Resistance in CAR-T Cells to Enhance Activity Against Solid Tumors.

Cancer research·2026

Paired Single-Cell Profiling Reveals Glutathione-Dependent Immune Evasion in Breast Cancer Liver Metastasis.

Cancer research·2026

ANXA1 Promotes Endoplasmic Reticulum-Mitochondria Calcium Coupling to Sustain Lenvatinib Resistance in Hepatocellular Carcinoma.

Cancer research·2026

The HDAC8-U2AF1 Axis Dysregulates DNA Damage-Responsive RNA Splicing and Creates Targetable Vulnerabilities in Acute Myeloid Leukemia.

Cancer research·2026

Single-Cell and Spatial Transcriptomics Reveal CHCHD3 as a Therapeutic Target to Activate cGAS-STING and Overcome Immunosuppression in Lung Adenocarcinoma.

Cancer research·2026

NGS-Guided Discovery of Cross-Reactive TfR1 VHH Antibodies with Distinct Brain Localization Profiles.

Journal of biochemistry·2026

[Salvage allogeneic hematopoietic stem cell transplantation in five patients with refractory angioimmunoblastic T-cell lymphoma complicated by hemophagocytic lymphohistiocytosis: a case series].

Zhonghua nei ke za zhi·2026

Related Experiment Videos

Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma

Related Concept Videos

Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma.

Drug response prediction in high-risk multiple myeloma.

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.

Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma.

Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker.

Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma.

INSR Armoring Protects CAR-NK and CAR-T Cells Against Tumor Stroma-Induced CAR Shedding by Maintaining Cholesterol Homeostasis.

Sodium-Glucose Cotransporter SGLT2 Supports Metabolic Fitness and Ferroptosis Resistance in CAR-T Cells to Enhance Activity Against Solid Tumors.

Paired Single-Cell Profiling Reveals Glutathione-Dependent Immune Evasion in Breast Cancer Liver Metastasis.

ANXA1 Promotes Endoplasmic Reticulum-Mitochondria Calcium Coupling to Sustain Lenvatinib Resistance in Hepatocellular Carcinoma.

The HDAC8-U2AF1 Axis Dysregulates DNA Damage-Responsive RNA Splicing and Creates Targetable Vulnerabilities in Acute Myeloid Leukemia.

Single-Cell and Spatial Transcriptomics Reveal CHCHD3 as a Therapeutic Target to Activate cGAS-STING and Overcome Immunosuppression in Lung Adenocarcinoma.

NGS-Guided Discovery of Cross-Reactive TfR1 VHH Antibodies with Distinct Brain Localization Profiles.

[Salvage allogeneic hematopoietic stem cell transplantation in five patients with refractory angioimmunoblastic T-cell lymphoma complicated by hemophagocytic lymphohistiocytosis: a case series].

Related Experiment Videos

Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma

Related Concept Videos

Related Articles